1282PResponder analysis based on patient-reported outcomes...

1282PResponder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab

D'Angelo, S P, Fofana, F, Schlichting, M, Henry-Szatkowski, M, Hennessy, M, Bharmal, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy289.038
Date:
October, 2018
File:
PDF, 90 KB
english, 2018
Conversion to is in progress
Conversion to is failed